Home Tools
Log in
Cart

Search Result

Search Results for " arq 197 "

3

Compounds

Cat No. Product Name Synonyms Targets
T6117 Tivantinib ARQ 197 Apoptosis , c-Met/HGFR
Tivantinib (ARQ 197) is an orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity.
T83557 (3S,4S)-Tivantinib ARQ 198,(3S,4S)-ARQ 197
(3S,4S)-Tivantinib, a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET, targets GSK3α and GSK3β—two novel enzymes implicated in the pathogenesis of non-small cell lung cancer (NSCLC) [1].
T83524 (rel)-Tivantinib (rel)-(3R,4R)-ARQ 198,(rel)-ARQ 197
(rel)-Tivantinib is a potent, highly selective inhibitor of the receptor tyrosine kinase c-MET and has additional novel targets, GSK3α and GSK3β, that are critical in the cellular mechanisms of non-small cell lung cancer...
TargetMol